Study of Safety, Tolerability and Efficacy of DFV890 in Participants With Familial Cold Auto-inflammatory Syndrome (FCAS) (DFV890-FCAS Trial)
Recruiting in Palo Alto (17 mi)
+4 other locations
Age: 18+
Sex: Any
Travel: May be covered
Time Reimbursement: Varies
Trial Phase: Phase 2
Waitlist Available
Sponsor: Novartis Pharmaceuticals
No Placebo Group
Prior Safety Data
Trial Summary
What is the purpose of this trial?The purpose of this phase II study was to assess the safety, tolerability and efficacy of DFV890 in participants with FCAS.
Eligibility Criteria
Participant Groups
1Treatment groups
Experimental Treatment
Group I: DFV890Experimental Treatment1 Intervention
DFV890
Find A Clinic Near You
Research locations nearbySelect from list below to view details:
Novartis Investigative SiteLa Jolla, CA
Loading ...
Who is running the clinical trial?
Novartis PharmaceuticalsLead Sponsor